Review reveals emerging multimodal treatments in colorectal cancer, indicating strong potential to improve patient survival and prognosis.
Colorectal cancer (CRC) is the third most common cancer worldwide, and the second most common cause of cancer-related death. Accordingly, there is ongoing research aiming to find new and improved treatment modalities for CRC that can increase survival and decrease overall morbidity and mortality. Current management strategies for CRC include surgery, radiotherapy, chemotherapy, and immunotherapy, in addition to their combination. Nevertheless, CRC management remains a major challenge. This review summarizes the most recent therapeutic approaches for CRC, with special emphasis on new strategies that are currently being studied and have great potential to improve the prognosis and lifespan of patients with CRC.
No takes yet. Share an insight, caveat, or question.
Metivishvili et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: